Literature DB >> 17519106

Pregnancies complicated by multidrug-resistant tuberculosis and HIV co-infection in Durban, South Africa.

M Khan1, T Pillay, J Moodley, A Ramjee, N Padayatchi.   

Abstract

SETTING: Tertiary hospitals in KwaZulu Natal, South Africa.
OBJECTIVE: To study the impact of multidrug-resistant tuberculosis (MDR-TB) and human immunodeficiency virus-1 (HIV-1) co-infection during pregnancy on maternal and perinatal outcome.
DESIGN: Prospective study performed between 1996 and 2001. Symptomatic pregnant women were investigated for TB. Those with confirmed MDR-TB were reported on.
RESULTS: Three of five pregnant women with MDR-TB were HIV-1 co-infected. One woman decided to terminate the pregnancy and one experienced pre-term labour. Two neonates had features of growth restriction.
CONCLUSION: Management of pregnant women with MDR-TB in an HIV-endemic area is possible in developing countries.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519106

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  10 in total

Review 1.  Clinical Pharmacokinetics and Pharmacodynamics of Anti-Tubercular Drugs in Pregnancy.

Authors:  Jennifer R Shiu; Alan Min; Tony K L Kiang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-01       Impact factor: 2.441

2.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

Review 3.  Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps.

Authors:  Jyoti S Mathad; Amita Gupta
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

4.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

Review 5.  Tuberculosis care for pregnant women: a systematic review.

Authors:  Hang Thanh Nguyen; Chiara Pandolfini; Peter Chiodini; Maurizio Bonati
Journal:  BMC Infect Dis       Date:  2014-11-19       Impact factor: 3.090

6.  Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis.

Authors:  Marian Loveday; Sindisiwe Hlangu; Jennifer Furin
Journal:  Emerg Infect Dis       Date:  2019-03       Impact factor: 6.883

7.  Impact of multidrug-resistant tuberculosis and its medications on adverse maternal and perinatal outcomes: protocol for a systematic review and meta-analysis.

Authors:  Kefyalew Addis Alene; Akilew Awoke Adane; Alemken Jegnie
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

8.  "Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis.

Authors:  Marian Loveday; Sindisiwe Hlangu; Jennifer Furin
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

9.  Tuberculosis clinical presentation and treatment outcomes in pregnancy: a prospective cohort study.

Authors:  Brittney J van de Water; Meredith B Brooks; Chuan-Chin Huang; Letizia Trevisi; Leonid Lecca; Carmen Contreras; Jerome Galea; Roger Calderon; Rosa Yataco; Megan Murray; Mercedes C Becerra
Journal:  BMC Infect Dis       Date:  2020-09-18       Impact factor: 3.090

10.  Multidrug-Resistant Tuberculosis during Pregnancy: Two Case Reports and Review of the Literature.

Authors:  Minakshi Rohilla; Bharti Joshi; Vanita Jain; Jasvinder Kalra; G R V Prasad
Journal:  Case Rep Obstet Gynecol       Date:  2016-02-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.